structural change in the business outlook of PET, and is an oppor- tunity for well-managed and committed PET producers like IVL to align supply reliability to customers. We benefitted from the instability

will be a new item namely “Contract assets”, representing the difference between the revenue recognized and the upfront cash received from customers as well as capitalized device subsidies. Market and

summarized as follows: Consolidated FS Quarter 1/2019 Quarter 1/2020 Change MB. % MB. % MB. % Revenue from contracts with customers 1,943.6 70.9% 1,714.0 64.3% -229.6 -11.8% Interest income from loans from the

registration statement, or, if not, how it proposes to provide the additional working capital needed; (b) an evaluation of the sources and amounts of the issuer's cash flows from operating, investing and

margin of 23.5 percent. The details on the performance of the companies in the group can be described as follows: Summary of Income Statement Q3/2018 Q3/2017 Change 9M/2018 9M/2017 Change MB MB % MB MB

Microsoft Word - MDA 2017 EN SET Final.docx Page 1 of 5    L-WAVE ENT 28/2018 28 February 2018 Subject: Report on reasons of change to profit (loss) and analysis on operating results by the

of debt as shown in the consolidated financial statement of debenture issuer, deducted by cash and cash equivalents" to" the total liabilities only with the interest-bearing debt as shown in the

cost from interest payment and short-term loan financing fee related to the acquisition of GLOW Operating Results Overall Operating Results of the Company and its Subsidiaries 1 Q1/18 Q4/18 Q1/19 Change

www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the

for the organization. Lastly, other operational plans that are supportive of the change will be implemented. The gross income of the Company and subsidiary companies in Q3/2017 is 2,346.48 million THB